NCT06048133 Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06037980 CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence Status RECRUITING Phase PHASE2/PHASE3
NCT06010862 Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT05993429 Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma Status COMPLETED Phase N/A
NCT05967182 A Single-Arm Study of Pembrolizumab With Gemcitabine and Cisplatin as Perioperative Therapy for Potentially Resectable Intrahepatic Cholangiocarcinoma Status RECRUITING Phase PHASE2
NCT05957250 [68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer Status RECRUITING Phase NA
NCT05948475 Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05876754 An Early Access Study of Ivosidenib in Patients With a Pretreated Locally Advanced or Metastatic Cholangiocarcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05874414 Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma Status RECRUITING Phase PHASE1/PHASE2
NCT05872867 Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) Status RECRUITING Phase PHASE1
NCT05724563 Domvanalimab and Zimberelimab in Advanced Liver Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05721963 Study on the Accuracy of Proteomics in Evaluating Lymph Node Metastasis Status in Cholangiocarcinoma Patients Status UNKNOWN Phase N/A
NCT05712356 A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE2
NCT05697237 Carlizumab Plus Sovantinib in Second-line Treatment of Advanced or Metastatic Cholangiocarcinoma Status UNKNOWN Phase NA
NCT05694845 Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma Status NOT_YET_RECRUITING Phase N/A